3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
16
Neoplasms
4
Neoplasm Metastasis
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Giant Cell Tumor of Bone
3
Carcinoma, Renal Cell
3
Smoldering Multiple Myeloma
2
Recurrence
2
Osteoporosis
2
Melanoma
2
Kidney Neoplasms
2
Bone Cysts, Aneurysmal
2
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Cancer Metastatic
1
Parathyroid Neoplasms
1
Osteoporotic Fractures
1
Osteopetrosis, mild autosomal recessive form
1
Osteopetrosis, Autosomal Recessive 7
1
Osteoblastoma
1
Neoplastic Cells, Circulating
1
Musculoskeletal Pain
1
Mastocytosis, Systemic
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hyperparathyroidism, Primary
1
Granuloma, Giant Cell
1
Giant Cell Tumors
1
Interventions
Surgical Procedures, Operative
1
Fracture Fixation, Intramedullary
1
Denosumab
1
Data Collection
1
Dalteparin
1
Bone Plates
1
Arthroplasty, Replacement, Hip
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fractures, Spontaneous
×
Denosumab
×
Clear all
NCT03415477
2018-01-30
Deno-ABC
Peking University People's Hospital
Phase 1/2
Completed
6 enrolled